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Objectives The aim of the longitudinal PARTAGE study was to determine the predictive value of blood pressure (BP) and
pulse pressure amplification, a marker of arterial function, for overall mortality (primary endpoint) and major
cardiovascular (CV) events, in subjects older than 80 years of age living in a nursing home.
Background Assessment of pulse indexes may be important in the evaluation of the CV risk in very elderly frail subjects.
Methods A total of 1,126 subjects (874 women) who were living in French and Italian nursing homes were enrolled
(mean age, 88  5 years). Central (carotid) to peripheral (brachial) pulse pressure amplification (PPA) was cal-
culated with the help of an arterial tonometer. Clinical and 3-day self-measurements of BP were conducted.
Results During the 2-year follow-up, 247 subjects died, and 228 experienced major CV events. The PPA was a predictor
of total mortality and major CV events in this population. A 10% increase in PPA was associated with a 24%
(p  0.0003) decrease in total mortality and a 17% (p  0.01) decrease in major CV events. Systolic BP, diastolic BP,
or pulse pressure were either not associated or inversely correlated with total mortality and major CV events.
Conclusions In very elderly individuals living in nursing homes, low PPA from central to peripheral arteries strongly predicts
mortality and adverse effects. Assessment of this parameter could help in risk estimation and improve diagnos-
tic and therapeutic strategies in very old, polymedicated persons. In contrast, high BP is not associated with
higher risk of mortality or major CV events in this population. (Predictive Values of Blood Pressure and Arterial
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1503–11) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.055PHRC of the French Ministry of Health (Registered AFSSAPS: 2006-A00042-49).
Supplementary financial support from the French Society of Hypertension, the FRM
(DCV20070409250), Boehringer Ingelheim France Laboratories, Inserm, and the PPF of
the French Ministry of Research. The study was conducted with the logistic support of the
Centre of Clinical Investigations (INserm CIC-P) and the Centre of Clinical Epidemi-
ology (Inserm CIC-EC) of the University Hospital of Nancy. Dr. Salvi is a consultant for
DiaTecne, Milan, Italy. All other authors have reported that they have no relationships
relevant to the contents of this paper to disclose.From the *Inserm U961, Nancy, France; †CHU Nancy, Clinical Investigation Center,
IC 9501, Nancy, France; ‡Universite de Lorraine, Nancy, France; §CHU Nancy,
epartment of Geriatrics, University Hospital of Nancy, Nancy, France; Department of
Cardiology, IRCCS Istituto Auxologico Italiano, Milan, Italy; ¶Division of Internal
Medicine, Sacro Cuore Hospital, Negrar, Verona, Italy; #Department of Geriatrics,
University Hospital of Verona, Verona, Italy; **Department of Geriatrics, Inserm U1027,
Toulouse University Hospital, Toulouse, France; ††Diagnosis Center, Hôtel-Dieu
Hospital, Paris, France; ‡‡Broca Hospital, University Descartes Paris 5, Paris, France;
§§Department of Geriatrics, University Hospital of Dijon, Dijon, France; and Inserm
IC-EC, University Hospital of Nancy, Nancy, France. Primary financial support from
Manuscript received February 13, 2012; revised manuscript received March 30,
2012, accepted April 3, 2012.
s
c
p
t
A
i
b
s
c
a
C
p
2
1504 Benetos et al. JACC Vol. 60, No. 16, 2012
Pulse Pressure Amplification and Events in Elderly Subjects October 16, 2012:1503–11The dramatic increase in the num-
ber of elderly people, especially those
80 years of age and older, has
translated into a growing popula-
tion that is increasingly prone to
frailty, multiple comorbidities, and
partial loss of autonomy. This is
now one of the target populations
for geriatric medicine, necessitat-
ing the development of specific
diagnostic and therapeutic ap-
proaches (1). These approaches
cannot be derived, however, from
a simple extrapolation of the strat-
egies applied in younger popula-
tions or even in very elderly robust
populations. Thus, assessment of
cardiovascular (CV) risk in these in-
dividuals represents a major issue.
High blood pressure (BP), especially systolic hyperten-
sion, is a major determinant of morbidity and mortality in
the elderly (2) In addition, a decrease in BP with antihy-
pertensive treatment in individuals 80 years of age or older
has been shown to be beneficial (3). However, these results
were obtained in community-dwelling individuals without
major comorbidities. Actually, the association between BP
levels and morbidity and mortality in very elderly persons
with several comorbidities remains a controversial issue,
with several studies showing a lack of such a relationship
(4–6) or even an inverse relationship (7,8). It is therefore
logical to seek alternative approaches to estimate CV risk in
these individuals. Assessment of arterial mechanical prop-
erties by measuring pulse indexes such as pulsed wave
velocity (PWV), pulse contour analysis, and pulse pressure
(PP) amplification (PPA) may be of interest in this respect.
The recent development of several noninvasive validated
devices has allowed the possibility of such measurements in
several populations (9,10). Clinical studies have shown in
middle-age and older populations that such measurements
can provide additional BP information for the prediction of
CV risk (11,12). To date, no large study has evaluated the
predictive value of PP and of pulse indexes for morbidity and
mortality in very elderly individuals living in nursing homes.
The aim of the present study was to evaluate the
prognostic value of arterial mechanical parameters (PPA
and PWV) and BP on total mortality and major CV events
in very elderly individuals living in nursing homes.
Methods
The PARTAGE (Predictive Values of Blood Pressure and
Arterial Stiffness in Institutionalized Very Aged Population)
study is a multicenter, longitudinal study aimed at determining
the 2-year predictive value of BP and arterial functional
parameters on total mortality (primary endpoint) as well as
Abbreviations
and Acronyms
ADL  activity of daily
living
AI  augmentation index
CV  cardiovascular
DBP  diastolic blood
pressure
MAP  mean arterial
pressure
PP  pulse pressure
PPA  pulse pressure
amplification
PWV  pulsed wave
velocity
SBP  systolic blood
pressuremajor CV outcomes and cognitive decline (secondary end-points) in a large population of individuals 80 years of age and
older living in nursing homes. The rationale and baseline
parameters of this study were previously described (13).
Participants were enrolled in 4 French (Nancy, Dijon,
Paris, Toulouse) and 2 Italian (Cesena and Verona) univer-
sity hospital centers between January 2006 and June 2008. A
total of 72 nursing homes participated in this study in
France and Italy (13).
Participants were included if they were 80 years of age
and over, living in nursing homes, and signed the informed
consent. Subjects were excluded if they had severe dementia
(Mini-Mental Status Examination score 12 out of 30), a
low level of autonomy (Activity of Daily Living [ADL]
scale score 2 out of 6) or were under guardianship or
ome measure of legal protection. No other exclusion
riteria were applied. The family and/or the physician of the
atient were informed of the study and gave their approval.
According to the inclusion criteria, 1,259 individuals living in
he nursing homes participating in this study were eligible.
mong them, 1,130 (89%) agreed to participate and were enrolled
n this study. Four subjects were excluded from the present analysis
ecause they did not have self-measured BP. Therefore, 1,126
ubjects (874 women and 252 men) were analyzed.
This study was approved by the respective regional ethics
ommittees in France (Comité de Protection des Personnes)
nd in Italy (Comitato Etico Area Vasta Romagna and
omitato Etico della Provincia di Verona), and all partici-
ants gave written informed consent before the study.
-year follow-up. Patients were included from January
2007 to June 2008 and were followed for 2 years. Adverse
outcomes were recorded every 3 months from inclusion to
the end of the study, using a questionnaire addressed to the
physicians at each nursing home. In addition, 2 visits were
conducted by the study investigators at the end of the first
and second year of follow-up.
Clinical data collection. All geriatric assessment instru-
ments and arterial measurements were performed in the
nursing homes by a trained medical research investigator
present at each university hospital center participating in the
study. Clinical data collection was performed during face-to-
face interviews and acquired from the patients’ medical records.
Arterial functional parameters. Central BP values and
aortic pressure waveforms were obtained directly from the
common carotid artery using an applanation tonometer (9,14).
Arterial tonometry was performed on right common carotid
artery and femoral artery using a PulsePen device (DiaTecne
srl, Milan, Italy) (10). As previously demonstrated, the pressure
waves recorded noninvasively by the PulsePen tonometer at the
site of the common carotid artery are similar to pressure
waveforms obtained invasively by means of an intra-arterial
catheter (10). Moreover, several studies demonstrated that
central BP values and pulsed wave analysis recorded in the
common carotid artery are a reliable surrogate of analysis
recorded in the aorta by invasive methods (9,12,15). Central
BP values were obtained by the carotid BP curve integral after
calibration with brachial mean and diastolic BP (DBP) mea-
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October 16, 2012:1503–11 Pulse Pressure Amplification and Events in Elderly Subjectssured noninvasively by a validated oscillometric sphygmoma-
nometer (16) at the brachial artery (Omron 705IT, Omron
Co., Kyoto, Japan). The PPA was the percentage of increase of
PP in the brachial artery (PPB) relative to central PP (PPC),
according to the formula: PPA  100 · (PPB  PPC)/PPC.
The augmentation index (AI) was measured from the analysis
of carotid pulsed waves according to the previously reported
method (10).
The PulsePen device was also used for measuring carotid-
femoral PWV, which is considered the gold standard for
measuring arterial stiffness (10,11,13). The procedure was
described in detail previously (13). For technical reasons,
arterial measurements were not obtained in 66 (for PPA and
AI) and 56 (for PWV) subjects.
BP measurement. BP and heart rate measurements were
performed at the brachial artery level using the validated
automated oscillometric device Colson DM-H20 (Dupont
Médical, Frouard, France). The midarm circumference was
measured and the cuff width adapted accordingly.
Self-measurements of BP were performed following the
“rule of 3” (3 measurements with intervals of 1 min in the
morning and evening for 3 consecutive days) according to
the protocol proposed by the French Society of Hyperten-
sion (17). The procedure was described previously (13). In
the present study, the average of the BP values of the 3 days
(morning and evening) was used for the different analyses.
Main Clinical Characteristics in Men and WomeTable 1 Main Clinical Characteristics in Me
Parameters All
n (%) 1,126
Age, yrs 88 5
BMI, kg/m2 26 5
MMSE score, 0–30 23 5
Katz ADL scale score, 0–36 5.0 1.1
Charlson comorbidity index 6.0 1.9
Smoking (past  current), % 22
Total no. of drugs 7.1 3.4
History of CV disease, % 52
Diabetes, % 16
Dyslipidemia, % 25
History of hypertension, % 72
Current hypertension treatment, % 95
No. of antihypertensive drugs 2.2 1.0
SBP, mm Hg 138 17
DBP, mm Hg 73 9
PP, mm Hg 65 13
Heart rate, beats/min 74 11
AI 28 14
CF PWV, m/s 14.3 5.1
Central PP, mm Hg 55 15
PPA, % 24 10
2-yr total mortality, % 22
2-yr major CV events, % 22
Values are mean SD or %. *p values determined with Wilcoxon rank
test for mortality and major CV events.
ADL activities day living; AI augmentation index; BMI bodyma
DBP  diastolic blood pressure; MMSE  Mini-Mental Status Examination; P
central/central); SBP  systolic blood pressure.Mean arterial pressure (MAP) was calculated as: DBP 
1/3 PP.
Endpoints. The primary endpoint was overall mortality
during the 2-year follow-up period.
The secondary pre-specified endpoints were major CV
events. Major CV events (CV morbidity and mortality)
included both nonfatal CV events that led to hospitalization
or a specific long-term new treatment as well as death from
cardiac, cerebrovascular, and other vascular causes.
Information on the cause of death and adverse cardiac events
were reported by the physicians at the nursing homes every 3
months according to the procedure detailed previously.
According to the reported information, 2 investigators in
our group (S.G., P.S.) classified subjects with or without
CV events. At the end of the study, all events were
re-evaluated in a blinded manner by a third investigator
(A.B.). In few cases, in which the 2 classifications differed,
a third consensus review was conducted with the 2 investi-
gators. Less than 5% of such differences were observed, and
in all cases, consensus was reached during the consensus
meetings.
Statistical analysis. Descriptive values are expressed as
mean  SD or number and percentage. For the compari-
ons of men and women (Table 1), the Wilcoxon rank sum
est was used for continuous variables, the chi-square test for
iscrete variables, and the log-rank test for 2-year mortality
Women
Men Women p Value*
252 (22) 874 (78)
87 5 88 5 0.25
25 4 26 5 0.17
24 5 23 5 0.25
5.0 1.1 5.0 1.0 0.59
6.5 2.0 5.9 1.8 0.00001
61 10 0.00001
6.5 3.1 7.2 3.4 0.007
58 50 0.034
17 16 0.89
21 26 0.12
60 76 0.00001
91 96 0.0057
2.1 0.9 2.2 1.1 0.18
135 17 138 17 0.002
73 9 73 9 0.71
62 13 66 13 0.00001
73 12 74 10 0.042
23 15 29 13 0.00001
15.0 5.4 14.1 5.0 0.045
53 16 55 15 0.03
23 11 24 10 0.57
33 19 0.00001
25 21 0.16
st for continuous variables, 2 test for discrete variables, and log-rank
x; CF PWV carotid-femoral pulse wave velocity; CV cardiovascular;nn and
sum te
ss inde
P  pulse pressure; PPA  pulse pressure amplification (peripheral-
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Pulse Pressure Amplification and Events in Elderly Subjects October 16, 2012:1503–11and major CV events. Univariate correlations were made
with Pearson’s parametric test. The occurrence of total
mortality and major CV events according to tertiles of each
hemodynamic parameter was estimated using Kaplan-Meier
curves for graphic representation and compared by the
log-rank test. Cox regression multivariate models were used
to assess the relative risk (hazard ratio and 95% confidence
interval) of total mortality and of major CV events, accord-
ing to each hemodynamic parameter as a continuous vari-
able. According to the univariate analyses, the following
variables were associated at the 0.10 level with total mor-
tality and subsequently included in the multivariate Cox
models: sex, age, ADL, body mass index, Charlson comor-
bidity index, and history of CV disease. For major CV
events, by using the same procedure, age, ADL, a history of
CV disease, and the presence of antihypertensive treatment
were included. For PPA and PWV, additional adjustments
for MAP and heart rate were made. This was necessary to
ascertain whether the possible effect of PPA on endpoints
was independent of BP and heart rate. The interaction
between arterial parameters and current antihypertensive
treatment on mortality and major CV events was tested with
the Cox model by including the interaction term in the
model. The term relative risk is used for hazard ratio
throughout this paper. The proportional hazards assump-
tion was assessed on the basis of a test of Schoenfeld
residuals with the Cox regression using NCSS 2000 soft-
ware (NCSS, LLC, Kaysville, Utah). A p value 0.05 was
considered statistically significant. Statistical analyses were
performed using NCSS 2000 statistical software package.
Figure 1 Flow Chart With Data Concerning Deaths and Major C
Among the 1,126 subjects enrolled in the study, 839 completed the 2-year follow-
During the 2-year follow-up, 228 subjects experienced major cardiovascular (CV) eResults
Among the 1,126 subjects of a mean age of 88  5 years,
78% were women. Table 1 shows the main demographic
and clinical characteristics of the men and women as well as
the rates of total mortality and major CV events.
Table 2 shows that among arterial functional parameters,
PWV showed the strongest relationship with MAP,
whereas PPA showed the weakest relationship with MAP.
Interestingly, PWV was not correlated with PPA. Multi-
variate analysis showed that PPA was positively associated
with heart rate (p  0.001) and negatively associated with
ge (p  0.002) and AI (p  0.02). Sex, MAP, and PWV
ere not associated with PPA on multivariate analysis.
elationships of PPA and PWV with total mortality and
ajor CV events. Among the 1,126 patients enrolled in
he study, 839 completed the 2-year follow-up (Fig. 1).
mong the remaining 287 subjects, 247 died and 40 were
ost to follow-up. During the 2-year follow-up, 228 subjects
ents During the Follow-Up Period
7 died, and 40 were lost to follow-up.
Correlation Coefficients (Pearson)of Univariate Correlations BetweenBlood Pressure and Arterial Parameters
Table 2
Correlation Co ffici nts (Pearson)
of Univariate Correlations Between
Blood Pressure and Arterial Parameters
PP Central PP PPA PWV AI
MAP 0.38‡ 0.33‡ 0.07* 0.19‡ 0.11‡
PP 0.95‡ 0.10† 0.22‡ 0.17‡
Central PP 0.39‡ 0.19‡ 0.20‡
PPA 0.02 0.16‡
PWV 0.19‡
*p  0.05. †p  0.01. ‡p  0.001.
MAP  mean arterial pressure; other abbreviations as in Table 1.V Ev
up, 24
vents.
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October 16, 2012:1503–11 Pulse Pressure Amplification and Events in Elderly Subjectsexperienced major CV events. At the 6 centers, no signifi-
cant differences were observed for total mortality (20% to 28%;
p  0.34) and major CV events (19% to 33%; p  0.10).
Figure 2 shows the survival curves for total mortality and
ajor CV events according to the tertiles of PPA and
WV. A lower PPA was significantly associated with both
igher total mortality (p  0.003) and more major CV
vents (p  0.004). By contrast, PWV was not associated
ith total mortality or with major CV events.
The role of PPA and PWV in total mortality or major
V events was also assessed by considering these parameters
s continuous variables. Figure 3 depicts the relationships
etween PPA and total mortality (Fig. 3A) or major CV
vents (Fig 3B). On both univariate and multivariate anal-
ses, the higher the PPA was, the lower the total mortality
nd major CV events. In this multivariate model, a 10%
ncrease in PPA was associated with a significant 24%
ecrease in total mortality and 17% decrease in major CV
vents. Older age, low ADL scale score, and low body mass
ndex were determinants of total mortality (Fig. 3A). In
ddition, male sex (p  0.0003), high Charlson morbidity
ndex score (p  0.045), low MAP (p  0.026), and high
eart rate (p  0.0007) were independent determinants of
otal mortality. A low ADL scale score was associated with
ajor CV events (Fig. 3B).
Figure 2 Survival Curves (Log-Rank Analyses) for Total Mortali
in 1,126 Subjects According to the Tertiles of PPA an
Tertiles were defined, respectively, as low (L), mid (M), and high (H). PPA: 0 to 18
PWV: 6.0 to 11.5 m/s, 11.6 to 15.5 m/s, 15.6 to 35.0 m/s; PPA  pulse pressuWith regard to PWV, the multivariate analyses con-
rmed the results of the univariate analyses (i.e., the absence
f any relationship between PWV and total mortality or
ajor CV events) (Table 3). A strong interaction was found
etween antihypertensive treatment and PWV in major CV
vents (p  0.001) and was still significant after adjustment
or covariates (p 0.002). After these results, we conducted
eparate analyses to assess the influence of PWV on major
V events in subjects with and without antihypertensive
herapy. In subjects not receiving antihypertensive treat-
ent (n  231), an increase in PWV of 1 m/s was
ssociated with a 9% higher risk of major CV events (p 
.003) (Fig. 4). By contrast, in subjects receiving antihyper-
ensive treatment (n  895), no such an association was
ound. No association was found between the AI and total
ortality or major CV events in the entire population and in
he subgroups with or without treatment (data not shown).
elationships between BP and total mortality and major
V events. Figure 5 shows the survival curves for total
ortality and major CV events according to the tertiles of
elf-measured BP. Higher mortality was significantly asso-
iated with lower DBP (log-rank, p  0.021). The associ-
ation between SBP or PP tertiles and total mortality did not
reach significance (p  0.057 and p  0.15, respectively).
No association was found between any of the BP measure-
d Major CV Events
V
8.9 to 28.0; 28.1% to 58.7%;
plification; PWV  pulsed wave velocity.ty an
d PW
.8%, 1
re am
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Pulse Pressure Amplification and Events in Elderly Subjects October 16, 2012:1503–11ments and major CV events. Central PP (not shown) was
not associated with total mortality or major CV events. The
results of the multivariate analyses are shown in Table 3. A
10-mm Hg increase in SBP, DBP, or MAP was associated
with a significant decrease in the risk of total mortality by
9%, 16%, and 15%, respectively. BP levels were not associ-
ated with major CV events (Table 3).
With regard to BP levels, similar results were observed
when BP measured by a clinician, instead of self-measured
BP, was considered (data not shown).
Discussion
This longitudinal study performed in subjects 80 years of
age and older and living in nursing homes provides 2 major
original findings. 1) The increase in PP from central
Figure 3 Relationships Between PPA and Total Mortality or Ma
Relative risk (hazard ratio [95% confidence interval (CI)]) for total mortality (A) and
variate or multivariate Cox models. The multivariate analyses also present the risk
body mass index (BMI) (1 kg/m2) (only for total mortality). This multivariate Cox m
tory of CV disease, MAP, and heart rate. For major CV events (B), the multivariate
presence of antihypertensive treatment, mean arterial pressure, and heart rate. Pr(carotid) to peripheral (brachial) arteries is a good predictorof total mortality and major CV events in this population.
The lower the PPA is, the higher the total mortality and
major CV events. 2) Self-measured BP is either not
associated or inversely associated with total mortality and
major CV events, confirming previously reported data
obtained with standard BP measurements in very elderly
subjects.
Influence of PPA on total mortality and major CV
events. Several reports have indicated interest in assessing
PPA to predict CV complications and benefits of antihy-
pertensive treatment (12,18,19). We recently reported in a
large middle-age population study (20,21) that calculated
PPA was strongly associated with both CV and total
mortality and that this association was stronger than the
association between mortality and central or peripheral PP,
V Events Assessed on Both Univariate and Multivariate Analyses
CV events (B) corresponding to the 10% increment in the PPA assessed in uni-
d to the increase in age (1 year), activities of daily living (ADL) (1 point), and
r total mortality (A) was also adjusted for sex, Charlson comorbidity index, his-
nalysis was also adjusted for Charlson comorbidity index, history of CV disease,
probability; other abbreviations as in Figure 2.jor C
major
relate
odel fo
Cox a
ob each taken separately.
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October 16, 2012:1503–11 Pulse Pressure Amplification and Events in Elderly SubjectsThe present longitudinal analysis shows that an increase
of 10% in PPA (corresponding to 1 SD) was associated
with a decrease of 24% and 17% in total mortality and major
CV events, respectively. Of note, the association between
PPA and the endpoints was markedly significant after
adjusting for several confounders, including history of CV
disease. This adjustment was necessary because in a cross-
sectional analysis of the baseline data of the present study
(22), we demonstrated a link between a history of heart
disease and PPA levels. We also tested this association after
adjusting for heart rate because the latter is a significant
determinant of PPA and may also influence CV events.
Again, the association between PPA and mortality or CV
events remained highly significant.
Influence of SBP, DBP, and PP on total mortality and
major CV events. This study provides significant new
information showing that PPA has a prognostic value in an
elderly population, whereas BP measurements do not. In
fact, in this population, the association between BP and
endpoints was either absent (for major CV events) or even
negative (for total mortality). Previous studies showed that
Risk Ratio (Cox Regression Analysis) forTotal Mortality and Major CV Event Accordingt B ood Pressure and Pulse Wave Veloc ty
Table 3
Risk R ti ( ox Regr ssi n Analysis) for
Total Mortality and Major CV Events According
to Blood Pressure and Pulse Wave Velocity
Risk Ratio 95% CI p Value
Total mortality
PWV, 1 m/s 1.00 0.97–1.03 0.792
SBP, 10 mm Hg 0.91 0.84–0.98 0.017
DBP, 10 mm Hg 0.84 0.72–0.99 0.037
MAP, 10 mm Hg 0.85 0.75–0.97 0.016
PP, 10 mm Hg 0.90 0.81–1.00 0.057
Major CV events
PWV, 1 m/s 1.00 0.98–1.03 0.797
SBP, 10 mm Hg 0.98 0.91–1.06 0.674
DBP, 10 mm Hg 0.97 0.84–1.13 0.716
MAP, 10 mm Hg 0.96 0.84–1.09 0.524
PP, 10 mm Hg 0.98 0.89–1.09 0.741
Each variable presented in this table was included in a multivariate Cox model with the following
covariates: age, sex, body mass index, activities of daily living, Charlson comorbidity index, and
history of CV disease for total mortality; age, activities of daily living, Charlson comorbidity index,
history of CV disease, and antihypertensive treatment for major CV events. For PWV, mean arterial
pressure and heart rate were added in the multivariate models.
CI  confidence interval; other abbreviations as in Tables 1 and 2.
Figure 4 Relative Risk (Hazard Ratio [95% CI]) for Major CV Ev
in PWV in Subjects Receiving (n  895) or Not Recei
The multivariate Cox analysis model included ADL, age, Charlson comorbidity inde
of CV disease, mean arterial pressure, and heart rate. tt  treatment; other abbrethe respective roles of SBP, DBP, and PP are modified with
advanced age with a weakening in the impact of DBP and
an increasing role of SBP and PP (23,24).
However, in the present study, similar results were also
observed for the other 2 components of BP (i.e., SBP and
PP). Previous relatively small studies in very elderly subjects
have reported the absence of any prognostic value of BP
(4–6) or even negative associations between BP levels and
morbidity and mortality (7,8). These paradoxical results can
be explained by the fact that in these very elderly frail
individuals, a low SBP may not simply be a sign of so-called
good arterial health but often of malnutrition and comor-
bidities such as heart failure, neurological disorders, and
other comorbidities associated with poor prognosis. Irre-
spective of the underlying explanation, the present results
indicate that the BP levels in very elderly frail individuals are
evidently not reliable, whereas PPA provides more pertinent
information about the patient’s prognosis. Interestingly,
PPA is a ratio of 2 pressures, and therefore this parameter is
weakly or even not related to absolute BP levels.
PWV, total mortality, and major CV events. In the
resent study, we found no relationship between PWV and
otal mortality or major CV events in the entire population.
n middle-age and elderly populations, high PWV, a strong
ndicator of high aortic stiffness, is a determinant of CV
vents (11,24–27). We previously showed in a smaller
opulation of subjects younger than 70 years of age living in
long-stay geriatric rehabilitation department that high
WV was associated with increased CV mortality but not with
otal mortality (6). In the present study, high PWV was
ssociated with major CV events only in individuals without
ntihypertensive treatment, probably because those who
ere treated had more comorbidities. This result may be
elated to the fact that although PWV is determined by
rterial structure and function, it is also influenced by BP
evels. Therefore, any comorbidity that tends to decrease BP
an also decrease PWV and therefore one can have a
elatively low PWV despite alterations in arterial mechan-
cal properties. However, contrary to what was observed
ith BP levels, high PWV was never associated with lower
otal mortality.
Corresponding to the 1-m/s Increment
(n  231) Antihypertensive Treatment
ory
s as in Figure 3.ents
ving
x, hist
viation
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Pulse Pressure Amplification and Events in Elderly Subjects October 16, 2012:1503–11Study limitations. The main limitation of the present
study is the absence of biological markers of frailty to better
understand the underlying conditions explaining these find-
ings. However, under the present conditions, the drawing of
blood in nursing homes could have potentially resulted in
the nonadherence of a large number of subjects with the
subsequent risk of selection bias.
Conclusions
Our results provide new information concerning the assessment of
risks in a dramatically growing elderly population living in nursing
Figure 5 Survival Curves (Log-Rank Analyses) for Total Mortali
in 1,126 Subjects According to the Tertiles of Self-Me
Tertiles were defined, respectively, as L, M, and H (mm Hg). SBP: 85.0 to 129.5,
106.5; PP: 25.5 to 58.3, 58.5 to 69.3, and 69.5 to 124.7. DBP  diastolic blood
as in Figure 2.homes and representing a major challenge for geriatric care. Theimportant finding is that in this frail population in which blood
pressure measurements may be misleading, PPA constitutes a
noninvasive appropriate method for assessing prognosis.
Of particular interest, these are polypathological, poly-
medicated individuals and are, in the large majority, treated
for hypertension. Although the design of the present study
does not allow the possibility to conclude on the previously
reported interest in controlling high BP with drugs (3), the
present findings do raise the issue of the utility of BP levels
as an indicator of protection in these individuals. This is of
major interest because iatrogenic-induced problems are also
d Major CV Events
ed SBP, DBP, and PP
to 143.7, and 143.8 to 201.3; DBP: 49.3 to 68.5, 68.6 to 76.3, and 76 to
ure; PP  pulse pressure; SBP  systolic blood pressure; other abbreviationsty an
asur
129.7
pressa major issue in the elderly.
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October 16, 2012:1503–11 Pulse Pressure Amplification and Events in Elderly SubjectsIn summary, low PPA from central to peripheral arteries
strongly predicts mortality and CV adverse events. Assess-
ment of this parameter could help in risk assessment and
improve diagnostic and therapeutic strategies in very elderly,
frail, and polymedicated persons. In contrast, high BP is not
associated with a higher risk of mortality and major CV
events in very elderly individuals living in nursing homes.
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